Idorsia Enrolls First Patients in QUVIVIQ Trial for US Label Update
Idorsia says it has enrolled the first patients in a QUVIVIQ trial seeking a US label update for daytime functioning benefits.
Idorsia says it has enrolled the first patients in a QUVIVIQ trial seeking a US label update for daytime functioning benefits.